Effects of dopamine partial-agonist aminoergolines on dopamine metabolism in limbic and extrapyramidal regions of rat brain

Biochemical Pharmacology

Volumn 47, Issue 10, 1994, Pages 1917-1919

  Baldessarini, Ross J ^a,b   Marsh, Elda R ^b   Huston Lyons, David ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

aminoergolines; autoreceptors; dopamine; ergolines; extrapyramidal; l DOPA; limbic; partial agonists; receptors; SDZ 208 911; SDZ 208 912; SDZ 212 327; SDZ MAR 327

Indexed keywords

3 HYDROXYBENZYLHYDRAZINE; APOMORPHINE; AUTORECEPTOR; DOPA; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ERGOLINE DERIVATIVE; GAMMA BUTYROLACTONE; N (2 CHLORO 6 METHYLERGOLIN 8ALPHA YL)PIVALAMIDE; N (2,6 DIMETHYLERGOLIN 8ALPHA YL)PIVALAMIDE; NEUROLEPTIC AGENT; PARTIAL AGONIST; SDZ 212327; SDZ MAR 327; UNCLASSIFIED DRUG;

AGONIST; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; EXTRAPYRAMIDAL SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; LIMBIC SYSTEM; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

4-BUTYROLACTONE; ANIMAL; DIHYDROXYPHENYLALANINE; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERGOLINES; EXTRAPYRAMIDAL TRACTS; HYDRAZINES; LIMBIC SYSTEM; MALE; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028303609     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(94)90323-9     Document Type: Article

References (15)

1. 2 agonist activity in the rat
2. Transdihydrolisuride, a partial dopamine receptor antagonist: Effects on monoamine metabolism
3. 2 dopamine receptor agonists
4. Partial dopamine-agonistic and atypical neuroleptic properties of the aminoergolines SDZ-208-911 and SDZ-208-912
5. Dopamine receptor subtypes: Their involvement in motor regulation
6. Structure activity relationship and therapeutic uses of dopaminergic ergots
7. Selective antidopaminergic effects of S(+)N-n-propylnoraporphines in limbic versus extrapyramidal sites in rat brain: Comparisons with typical and atypical antipsychotic agents
8. Differential agonist profile of the enantiomers of 3-PPP at striataldopamine autoreceptors: Dependence on extracellular dopamine
9. Effects of the partial dopamine receptor agonists SDZ-208-911, SDZ-208-912 and terguride on central monoamine receptors
10. 2 agonist, in the treatment of negative symptoms of chronic schizophrenia
11. Drugs and the treatment of psychiatric disorders
12. Dopamine autoreceptors
13. Effects of isomers of hydroxy-aporphines on dopamine metabolism in rat brain regions
14. Intrinsic activity of DA agonists
15. 2 guanine nucleotide-binding protein-coupled receptor: Utilization of receptor state binding affinities